Health and Fitness Health and Fitness
Thu, January 8, 2009
Wed, January 7, 2009

AMAG Pharmaceuticals, Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference


Published on 2009-01-07 14:08:48, Last Modified on 2009-01-07 14:09:11 - Market Wire
  Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian J.G. Pereira, MD, President and Chief Executive Officer, will present an overview of the Company at the 27th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2009 at 9:30 a.m. PT. The conference is being held in San Francisco, CA, January 12-15, 2009.

A live audio webcast of the presentation and breakout session will be accessible through the Investors section of the Company's website at [ www.amagpharma.com ]. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until February 10, 2009.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

Ferumoxytol is being developed for use as an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia and as a diagnostic agent for vascular-enhanced magnetic resonance imaging to assess peripheral arterial disease.